Comparison

Pardoprunox European Partner

Item no. TMO-T1769-1mg
Manufacturer TargetMol
CASRN 269718-84-5
Amount 1 mg
Quantity options 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Citations 1. Glennon JC, et al. Synapse. 2006 Dec 15;60(8):599-608.
Smiles O=C1OC2=C(C=CC=C2N1)N3CCN(C)CC3
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias SLV-308,DU-126891
Shipping Condition Cool pack
Available
Manufacturer - Targets
5-HT Receptor|||Dopamine Receptor|||Adrenergic Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
233.27
Description
Pardoprunox (SLV-308) is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties, used in trials for treating Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease.
Pathways
GPCR/G Protein|||Neuroscience
Bioactivity
Pardoprunox is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties. Pardoprunox has been used in trials studying the treatment of Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease.
Receptor
5-HT1A; alpha2-adrenergic receptor; D2; D3

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close